Dapsone Tablet
Product Images NDC 82804-988

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dapsone (NDC 82804-988). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Dapsone 01)

Chemical structure of Dapsone, showing two benzene rings connected by a sulfone (SO2) group with amine (NH2) groups attached to each benzene ring.*

FDA Label Image

82804-988-30 (Dapsone 02)

Label for Dapsone 25 mg oral tablets, containing 30 tablets per container. The label includes identification of the active ingredient as 25 mg Dapsone USP per tablet. It notes the tablets are round, white, scored, and debossed with "25" and "102", with "JACOBUS" on the obverse. The manufacturer is Everest Life Sciences LLC, Plainsboro, NJ, and the labeler is Proficient Rx LP.*

FDA Label Image

82804-989-30 (Dapsone 03)

Dapsone 100 mg tablets packaging label from Proficient Rx LP. The label specifies 30 tablets per package. Each tablet contains 100 mg of Dapsone, USP, described as round white scored tablets debossed with "100" above and "101" below the score, and "JACOBUS" on the obverse. Manufactured by Everest Life Sciences LLC, Plainsboro, NJ. Storage instructions indicate 20°-25°C (68°-77°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.